Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25

The aim of the present study was to investigate the anticancer effects and potential mechanisms of polyphenol epigallocatechin-3-gallate (EGCG) on breast cancer MCF-7 cells in vitro and in vivo. Our results showed that EGCG significantly inhibited MCF-7 cell viability in a time- and dose-dependent m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zan, Lingling, Chen, Qingfeng, Zhang, Lei, Li, Xiaona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738446/
https://www.ncbi.nlm.nih.gov/pubmed/31431131
http://dx.doi.org/10.1080/21655979.2019.1657327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738446/
https://www.ncbi.nlm.nih.gov/pubmed/31431131
http://dx.doi.org/10.1080/21655979.2019.1657327

Ejemplares similares